Myriad Genetics Announces Participation in Key Healthcare Events

Author: Henry Turner Updated: 08-27-2025 04:18 PM

Myriad Genetics to Engage in Major Healthcare Conferences

Myriad Genetics, Inc. (NASDAQ: MYGN), a pioneer in molecular diagnostic testing and precision medicine, has announced that its management team will be present at two forthcoming healthcare conferences. These events will focus on the company's innovative approaches to molecular diagnostics aimed at improving patient care.

Details of the Upcoming Conferences

The Wells Fargo Healthcare Conference

The first event is the Wells Fargo Healthcare Conference, set to include a fireside chat scheduled for Thursday, September 4, at 3:45 PM ET. This conference presents an opportunity for Myriad Genetics to share valuable insights into their advancements and future directions.

The Morgan Stanley Annual Global Healthcare Conference

Next, Myriad will participate in the Morgan Stanley Annual Global Healthcare Conference, which is planned for Wednesday, September 10, at 7:45 AM ET. This event will further highlight the company's commitment to enhancing patient outcomes through molecular insights in healthcare.

Access to Webcast and Archives

Investors and interested individuals can access both live and archived webcasts of these presentations at a dedicated investor relations page. This ensures that those who are unable to attend the events in real-time still have the opportunity to engage with the content shared by Myriad Genetics.

About Myriad Genetics

Myriad Genetics is committed to advancing health and well-being through groundbreaking molecular diagnostic testing. The company specializes in developing tests that evaluate the risk of disease and guide treatment decisions across various medical specialties. By leveraging molecular insights, Myriad aims to significantly enhance patient care and reduce healthcare costs.

For those seeking further information about Myriad's diverse offerings and corporate initiatives, their official website serves as a valuable resource for insights into their operational strategies and innovations.

Investor and Media Contacts

Investor Contact:
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact:
Kate Schraml
(224) 875-4493
PR@myriad.com

Frequently Asked Questions

What is Myriad Genetics known for?

Myriad Genetics is renowned for its molecular diagnostic testing and precision medicine, focusing on advancing health through innovative solutions.

When will Myriad Genetics participate in the conferences?

Myriad Genetics will participate in the Wells Fargo Healthcare Conference on September 4 and the Morgan Stanley Annual Global Healthcare Conference on September 10.

How can I access the conference presentations?

Live and archived webcasts of the presentations can be found on the investor relations page of Myriad Genetics.

Who should I contact for investor inquiries?

For investor inquiries, you can reach out to Matt Scalo at (801) 584-3532 or via email at IR@myriad.com.

What types of tests does Myriad Genetics provide?

Myriad Genetics offers molecular tests that evaluate disease risk and progression, aiding in critical treatment decisions across various medical fields.

About The Author

Hi there, As a writer and financial specialist, Henry Turner is passionate about guiding people through the complex world of finance. Having worked in finance for many years, I am an expert at simplifying difficult financial ideas into understandable, useful insights for my blog and articles. My goal is to arm you with the confidence and information you need to make wise financial choices.

Writing for a number of financial blogs has allowed me to interact with readers from novice investors looking for fresh ideas to seasoned investors starting their financial journeys. My mission is to enable everyone to understand and access finance, so enabling you to confidently and clearly reach your financial goals. I appreciate you traveling with me toward success and financial literacy.

Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.